Sunshine Guojian Pharmaceutical (shanghai) Co., Ltd.
Clinical trials sponsored by Sunshine Guojian Pharmaceutical (shanghai) Co., Ltd., explained in plain language.
-
New hope for back pain sufferers: drug 608 in final trial
Disease control Not yet recruitingThis study tests a new drug called 608 for people with a type of spinal arthritis that doesn't show up on X-rays. The goal is to see if it reduces pain and improves function. About 380 adults will receive either the drug or a placebo, and researchers will measure changes in sympt…
Phase: PHASE3 • Sponsor: Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd. • Aim: Disease control
Last updated May 17, 2026 02:45 UTC
-
New hope for ulcerative colitis sufferers: experimental drug enters phase 2 trial
Disease control Not yet recruitingThis study tests a new drug called SSGJ-627 in 288 adults with moderate to severe ulcerative colitis (UC). The goal is to see if it can safely reduce symptoms like bleeding and diarrhea. Participants must have tried other treatments without success. The drug is given in addition …
Phase: PHASE2 • Sponsor: Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd. • Aim: Disease control
Last updated May 04, 2026 16:30 UTC